During chemotherapy or radiotherapy for prostate cancer, damage to the cavernous nerve, a postganglionic branch of the pelvic ganglion, may lead to ED, and brain-derived neurotrophic factor (BDNF) promotes nerve regeneration by activating the JAK2/STAT pathway in Schwann cells[24, 25]. Here, JAK2 is linked to prostate cancer.